Ars Medika Center, LLC

Kaliningrad 236006

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Non-muscle Invasive Bladder Cancer

Studies at this site

• A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma — Running, not enrolling
• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling